Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
12 hedge funds and large institutions have $519K invested in Intellipharmaceuticals International Inc. in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
20% more funds holding
Funds holding: 10 → 12 (+2)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
78% less capital invested
Capital invested by funds: $2.33M → $519K (-$1.81M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.2M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$111K |
| 3 |
VF
Virtu Financial
New York
|
+$15.3K |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
+$265 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$83 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.31M |
| 2 |
Barclays
London,
United Kingdom
|
-$5K |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$949 |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$7 |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $469K | +$1.2M | +1,944,978 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $43K | +$111K | +180,877 | New |
|
|
VF
3
Virtu Financial
New York
| $6K | +$15.3K | +24,949 | New |
|
4
Morgan Stanley
New York
| $1K | – | – | – |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1 | -$1 | -1 | -14% |
|
|
AC
6
Armistice Capital
New York
| – | -$2.31M | -860,000 | Closed |
|
|
7
Barclays
London,
United Kingdom
| – | -$5K | -1,775 | Closed |
|
|
8
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$949 | -1,543 | -96% |
|
|
9
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$7 | -11 | -15% |
|
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$83 | +135 | +6% |
|
|
11
Bessemer Group
Woodbridge,
New Jersey
| – | +$265 | +430 | New |
|
IPCI Hedge Fund Activity: Q4 2018 in Review
12 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q4 2018, worth a combined $519K — down 78% from $2.33M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IPCI positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.2M. The largest seller was Armistice Capital, exiting entirely with an estimated $2.31M sold.
- 12 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q4 2018, up from 10 in Q3 2018.
- Funds reported $519K of Intellipharmaceuticals International Inc. stock for Q4 2018, down 78% quarter-over-quarter.
- 4 funds opened new Intellipharmaceuticals International Inc. positions in Q4 2018 and 2 closed out, a net change of +2 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q4 2018 was Sabby Management, an estimated $1.2M added.
- The largest Intellipharmaceuticals International Inc. seller in Q4 2018 was Armistice Capital, an estimated $2.31M sold.
Based on aggregated 13F filings for Q4 2018.